The University of Tennessee at Martin is monitoring and responding to the coronavirus outbreak for the safety and health of our community and the state of Tennessee. Questions and comments can be directed to Bud Grimes, Office of University Relations, firstname.lastname@example.org.
You can learn about the latest quarantine guidelines from the Centers for Disease Control and Prevention.
UT Martin will continue to follow current CDC and Tennessee Department of Health quarantine and isolation guidelines. Student Health and Counseling Services will conduct contact tracing for known student cases, and employees can consult with Human Resources.
Information Current 9-21-2021
Any student (including undocumented or international) who is or was enrolled at UT Martin during the COVID-19 national emergency may be eligible for financial aid grants through HEERF, regardless of whether they completed a FAFSA or are Title IV eligible. However, UTM must prioritize students with exceptional need, such as students who receive a Pell Grant or are undergraduates with exceptional financial circumstances.
Students who are or were enrolled on or after March 13, 2020, who demonstrate exceptional need due to COVID-19.
Initial CARE awards are made through an automated process based on the student’s Pell Grant eligibility and unmet need. Any student who does not receive the initial CARE award is encouraged to complete the CARE application to demonstrate their need. Students may choose whether they would like their awards added onto their student account or disbursed directly to them. CARE funds are available on a first-come, first-served basis.
CARE awards can be used for any component of the student’s cost of attendance or for emergency costs that arise due to COVID, such as tuition, food, housing, health care, or childcare. Students have the option to have the emergency grants refunded to them or directly onto their account.
Senior Exit Exams for Fall 2021: Effective Fall 2021 senior testing requirements will be reinstated, and all students will be required to complete both the General Education – Proficiency Profile and the major field exams.
2021 Fall Semester: Fall semester classes began on August 23. Fall break scheduled for October 18 and 19. The last day of classes will be December 3, and final exams will begin December 6. Courses will be delivered primarily in person, except for those that were typically offered online prior to the pandemic.
Dropping courses or withdrawing from the university after the drop deadline: Students who can verify one of the following situations may drop a single course or multiple courses or withdraw from the university after the drop deadline:
The Higher Education Emergency Relief Fund II (HEERF II) is authorized by the Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (CRRSAA), Public Law 116-260, signed into law on Dec. 27, 2020. UT Martin received funds to ensure learning continues for students during the COVID-19 pandemic. The institution was allocated $2.5 million for additional financial aid grants to students. Learn more about the student distribution.
The supplemental grant awarded to UT Martin of $6.4 million may be used for funds for Institutional Costs to defray expenses associated with coronavirus (including lost revenue, reimbursement for expenses already incurred, technology costs associated with a transition to distance education, faculty and staff trainings, and payroll); carry out student support activities authorized by the Higher Education Act of 1965, as amended (HEA) that address needs related to coronavirus; and make additional financial grants to students, which may be used for any component of the student’s cost of attendance or for emergency costs that arise due to coronavirus, such as tuition, food, housing, health care (including mental health care), or child care.
The Higher Education Emergency Relief Fund III (HEERF III) is authorized by the American Rescue Plan (ARP), Public Law 117-2, signed into law on March 11, 2021, providing over $7.5 million in support to serve students and ensure learning continues during the COVID-19 pandemic.
ARP funds are in addition to funds authorized by the Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (CRRSAA), Public Law 116-260 and the Coronavirus Aid, Recovery, and Economic Security (CARES) Act, Public Law 116-136. Emergency funds available to institutions and their students under all emergency funds total $7.9 million for UT Martin.
The U.S. Department of Education is providing guidance during the COVID-19 crisis, and regulatory relief is being reviewed frequently by Congress. Any changes will be posted in this FAQ.
Academic buildings will be open during the day. The building lockup process generally starts around 7 p.m.; buildings may need to remain open after 7 p.m. based on evening/night class schedules, use, and activity. Recreational facilities will be open to all registered students during operating hours, although hours might be more limited than in the past.
We continue to encourage all students and staff to consider receiving the COVID-19 vaccine. COVID-19 vaccines are effective at preventing COVID-19 and will help protect you without having to be sick. Vaccination is especially important for adults with underlying conditions because these individuals are at an increased risk from severe illness from COVID-19.
Vaccination against COVID-19 has several benefits. After you’ve been fully vaccinated, you can start to do some things you have stopped doing because of the pandemic and, if you have been around someone who has COVID-19, you do not need to quarantine or get tested unless you have symptoms. You still should continue taking steps to protect yourself and others.
Thank you for everything you do to help the UT Martin community stay well.
How do we know if COVID-19 vaccines are safe? COVID-19 vaccines were tested in large clinical trials to make sure they meet safety standards. Many people were recruited to participate in these trials to see how the vaccines offers protection to people of different ages, races, and ethnicities, as well as those with different medical conditions. The Food and Drug Administration (FDA) carefully reviews all safety data from clinical trials and an authorizes emergency vaccine use only when the expected benefits outweigh potential risks. The CDC’s Advisory Committee on Immunization Practices (ACIP) reviews all safety data before recommending any COVID-19 vaccine for use in the U.S. population. The FDA and CDC will continue to monitor the safety of COVID-19 vaccines, to make sure even very rare side effects are identified.
Messenger RNA or mRNA Vaccines (COVID-19 vaccines): mRNA vaccines are being held to the same safety and efficacy standards as all other types of vaccines in the United States. The only COVID-19 vaccines the FDA will make available for use in the United States are those that meet these standards. While there are currently no licensed mRNA vaccines in the United States, researchers have been studying and working with them for decades. mRNA vaccines have been studied before for flu, Zika, rabies and cytomegalovirus (CMV). Beyond vaccines, cancer research has used mRNA to trigger the immune system to target specific cancer cells.
Does getting sick with COVID-19 provide better protection than the vaccine gives? Both COVID-19 and the vaccines are new. We do not know how long protection lasts for those who get infected or for those who are vaccinated. What we do know is that COVID-19 has caused very serious illness and death for a lot of people. If you get COVID-19, you also risk giving it to loved ones who may get very sick. Getting a COVID-19 vaccine is a safer choice. If I have tested positive for COVID-19 and have recovered, do I need to be vaccinated? Yes, even if you have already had COVID-19 you should be vaccinated. Experts do not yet know how long you are protected from getting sick again after recovering from COVID-19. Even if you have already recovered from COVID-19, it is possible—although rare—that you could be infected with the virus that causes COVID-19 again. If you were treated for COVID-19 with monoclonal antibodies or convalescent plasma, you should wait 90 days before getting a COVID-19 vaccine.
Not all people who are infected with Sars-CoV-2 develop COVID-19; however, even the asymptomatic can transmit the virus to others. (Source - Johns Hopkins Coronavirus Resource Center)
Thank you for your assistance, cooperation and understanding as we all work to keep the university safe.
The following resources are offered by the Tennessee Department of Health: